Cafepharma Today

February 3 2025 - Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner
Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner
What Trump’s second term could mean for PDUFA’s future
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Thermo Fisher's layoff spree continues with 300 cuts in Massachusetts
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

ViroPharma drug gets FDA priority review
Yahoo/AP
Tuesday, February 3, 2009 - 3:28pm
tags:
FDA, ViroPharma, Cinryze
Earnings Preview: Allergan
Seeking Alpha
Tuesday, February 3, 2009 - 3:26pm
tags:
earnings, Allergan
Tom Daschle Withdraws From HHS Nomination
WSJ Online
Tuesday, February 3, 2009 - 3:25pm
tags:
Tom Daschle
[video]Big Pharma in Focus
Yahoo/CNBC
Tuesday, February 3, 2009 - 3:24pm
tags:
Big Pharma, Merck, Schering Plough
Merck CEO: Eyeing 'Entire Spectrum' Of Possible Acquisitions
CNN Money
Tuesday, February 3, 2009 - 11:02am
tags:
Merck, buyouts
Pharma CEOs more confident than leaders of other industries
Fierce Biotech
Tuesday, February 3, 2009 - 10:58am
tags:
Pharma CEOs
FDA Commissioner Update: Timing Provides Clues
InVivo
Tuesday, February 3, 2009 - 9:28am
tags:
FDA
Two FDA New Product Decisions Expected This Week for Eli Lilly, Dyax
Seeking Alpha
Tuesday, February 3, 2009 - 9:26am
tags:
Dyax, Eli Lilly, Daiichi Sankyo, Effient, Prasugrel, Kalbitor
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
Yahoo
Tuesday, February 3, 2009 - 8:12am
tags:
King, layoffs, restructuring
Merck Posts Profit, Affirms Expectations
TheStreet.com
Tuesday, February 3, 2009 - 8:10am
tags:
Merck, earnings
Cell Therapeutics Is Down but Not Out
Seeking Alpha
Tuesday, February 3, 2009 - 7:57am
tags:
Cell Therapeutics, Spectrum Pharmaceuticals, cancer, biotech
Takeda's net sales rise by 11.8 per cent
Hays Pharma, UK
Tuesday, February 3, 2009 - 7:39am
tags:
Takeda, earnings
Schering-Plough swings to $442 mln. fourth-quarter profit
Marketwatch
Tuesday, February 3, 2009 - 7:12am
tags:
earnings, Schering Plough
Ahead of the Bell: Eli Lilly blood thinner
Yahoo/AP
Tuesday, February 3, 2009 - 7:10am
tags:
Eli Lilly, Prasugrel, blood thinners
Genentech, OSI Rise After Lung Cancer Data
TheStreet.com
Tuesday, February 3, 2009 - 6:14am
tags:
OSI Pharmaceuticals, Genentech, lung cancer, Tarceva, Avastin
Somaxon a Sell Pre-Silenor News
Yahoo/Zacks.com
Tuesday, February 3, 2009 - 6:13am
tags:
Somaxon, Silenor, insomnia, FDA
Blood-Cleansing Treatment Could Make Tysabri Safer
Bloomberg
Tuesday, February 3, 2009 - 6:11am
tags:
Tysabri, Elan, Biogen Idec, MS
Amgen Options Boiling on M&A Rumors
CNBC
Monday, February 2, 2009 - 9:59pm
tags:
Amgen
Bristol Shares Rise on Sanofi Takeover Talk
TheStreet.com
Monday, February 2, 2009 - 9:57pm
tags:
Sanofi, Bristol-Myers Squibb, buyouts
Earnings Preview: Schering-Plough
Seeking Alpha
Monday, February 2, 2009 - 9:56pm
tags:
earnings, Schering Plough

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information